HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Does use of hormonal contraceptives among women with thrombogenic mutations increase their risk of venous thromboembolism? A systematic review.

Abstract
Because use of combined oral contraceptives (COCs) confers some risk of venous thromboembolism (VTE), there is concern that this effect may be greater among women with thrombogenic mutations. We searched the MEDLINE and EMBASE databases for all articles published from January 1966 through September 2004 for evidence relevant to hormonal contraception and thrombogenic mutations. Of 301 articles identified by the search strategy, 16 evaluated COCs, and no studies were found for other hormonal methods. We used standard abstract forms and grading systems to summarize and assess the quality of the evidence. A total of 10 studies together provided "good" evidence of a greater risk of VTE (risk ratios of 1.3-25.1) and cerebral vein or cerebral sinus thrombosis among COC users with factor V Leiden mutation when compared with nonusers who have the mutation. The evidence for prothrombin and other thrombogenic mutations was not as strong as for factor V Leiden mutation. It is unclear whether the type of COC or duration of use modifies the risk of VTE among women with thrombogenic mutations.
AuthorsAnshu P Mohllajee, Kathryn M Curtis, Summer L Martins, Herbert B Peterson
JournalContraception (Contraception) Vol. 73 Issue 2 Pg. 166-78 (Feb 2006) ISSN: 0010-7824 [Print] United States
PMID16413847 (Publication Type: Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, Non-P.H.S., Research Support, U.S. Gov't, P.H.S., Review, Systematic Review)
Chemical References
  • Contraceptives, Oral, Hormonal
  • factor V Leiden
  • Factor V
  • Prothrombin
Topics
  • Contraceptives, Oral, Hormonal (adverse effects)
  • Factor V (genetics)
  • Female
  • Humans
  • Intracranial Thrombosis (genetics)
  • Mutation
  • Prothrombin (genetics)
  • Thromboembolism (chemically induced, genetics)
  • Thrombophilia (genetics)
  • Thrombophlebitis (chemically induced, genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: